Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447837 · ClinicalTrials.gov registry record · Phase 2
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
A Phase 2 study of Chronic Sinusitis, sponsored by Naryx Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 20
- Study locations
NCT00447837 is a Phase 2 study of Chronic Sinusitis that has completed, run by Naryx Pharma. The registered enrollment target is 180 participants, roughly in line with the 176-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target. The trial reports 20 study locations across 10 states.
The verdict
NCT00447837, a Phase 2 study of Chronic Sinusitis, has completed, sponsored by Naryx Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
Conditions Studied
Interventions
- DRUG SPRC-AB01
Study Locations (20)
California
- Central California Clinical Research - Fresno
- Allergy Research Foundation, Inc - Los Angeles
- Children's Hospital of Orange County - Orange
- Allergy Medical Group of the North Area Inc - Roseville
- Sacramento Ear, Nose & Throat - Sacramento
- Allergy & Asthma Medical Group and Research Center - San Diego
Florida
- Clinical Trials Management LLC - Boca Raton
- Allergy & Asthma Center / South Florida ENT - Fort Lauderdale
- Clinical Research of West Florida - Tampa
Georgia
- Nasal Sinus and Allergy Institute - Alpharetta
- Northeast Georgia Research Center - Gainsville
- Northside Ear, Nose & Throat - Roswell
Colorado
- 1st Allergy & Clinical Research Center - Centennial
- Colorado Otolaryngology Associates - Colorado Springs
Alabama
- Clinical Research Consultants - Hoover
Arkansas
- NEA Clinic - Jonesboro
Connecticut
- The Connecticut Sinus Center - Bridgeport
Kentucky
- Commonwealth Ear, Nose & Throat - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00447837
The ClinicalTrials.gov registry entry for NCT00447837 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 176-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target. The listed sponsor is Naryx Pharma, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which SPRC-AB01 is the first listed.
NCT00447837 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT00447837 about?
NCT00447837 is a clinical study titled "Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis". The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
What is the current status of trial NCT00447837?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2006-10. Estimated completion is 2008-01.
What conditions does trial NCT00447837 study?
This clinical trial studies the following conditions: Chronic Sinusitis.
What interventions are being tested in trial NCT00447837?
The interventions under investigation include: SPRC-AB01 (DRUG).
Who is sponsoring clinical trial NCT00447837?
This trial is sponsored by Naryx Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00447837 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
COMPLETED · Phase 2
-
Esmolol vs. Labetalol in Endoscopic Sinus Surgery
COMPLETED · Phase 2
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
COMPLETED · NA
-
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.